87 related articles for article (PubMed ID: 2517322)
41. Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy?
Lai KN; Ho CP; Chan KW; Yan KW; Lai FM; Vallance-Owen J
Q J Med; 1985 Oct; 57(222):677-88. PubMed ID: 4080957
[TBL] [Abstract][Full Text] [Related]
42. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes.
Wehrmann M; Bohle A; Bogenschütz O; Eissele R; Freislederer A; Ohlschlegel C; Schumm G; Batz C; Gärtner HV
Clin Nephrol; 1989 Feb; 31(2):67-76. PubMed ID: 2920470
[TBL] [Abstract][Full Text] [Related]
43. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
Li X; Li H; Chen J; He Q; Lv R; Lin W; Li Q; He X; Qu L; Suya W
Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
[TBL] [Abstract][Full Text] [Related]
44. Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure.
Warwick GL; Geddes CG; Boulton-Jones JM
Q J Med; 1994 Apr; 87(4):223-9. PubMed ID: 8208913
[TBL] [Abstract][Full Text] [Related]
45. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL;
Kidney Int; 2001 Apr; 59(4):1484-90. PubMed ID: 11260412
[TBL] [Abstract][Full Text] [Related]
46. Prognosis in steroid-treated idiopathic nephrotic syndrome in adults. Analysis of major predictive factors after ten-year follow-up.
Idelson BA; Smithline N; Smith GW; Harrington JT
Arch Intern Med; 1977 Jul; 137(7):891-6. PubMed ID: 879928
[TBL] [Abstract][Full Text] [Related]
47. [Prognosis and treatment of membranous glomerulonephritis-a 5-year prospective study].
Covic A; Căruntu ID; Marian D; Volovăţ C; Ghiciuc C; Costin C; Florea L; Cotuţiu C; Covic M
Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):63-74. PubMed ID: 12089993
[TBL] [Abstract][Full Text] [Related]
48. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.
Polenakovic M; Grcevska L; Dzikova S
Prilozi; 2006 Dec; 27(2):5-12. PubMed ID: 17211287
[TBL] [Abstract][Full Text] [Related]
49. Treatment of idiopathic membranous nephropathy with the herb Astragalus membranaceus.
Ahmed MS; Hou SH; Battaglia MC; Picken MM; Leehey DJ
Am J Kidney Dis; 2007 Dec; 50(6):1028-32. PubMed ID: 18037104
[TBL] [Abstract][Full Text] [Related]
50. Early initiation of immunosuppressive treatment in membranous nephropathy patients.
Chan CK; Lai TS; Chen PM; Chou YH; Wu CF; Chiu YL; Chiang WC; Chen YM; Chu TS; Wu KD
J Formos Med Assoc; 2017 Apr; 116(4):266-275. PubMed ID: 28202222
[TBL] [Abstract][Full Text] [Related]
51. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.
Torres A; Domínguez-Gil B; Carreño A; Hernández E; Morales E; Segura J; González E; Praga M
Kidney Int; 2002 Jan; 61(1):219-27. PubMed ID: 11786104
[TBL] [Abstract][Full Text] [Related]
52. [Membranous glomerulonephritis: better therapy with autoantibody monitoring?].
Stahl RA; Hoxha E; Helmchen U
Dtsch Med Wochenschr; 2011 Aug; 136(34-35):1733-7. PubMed ID: 21877306
[TBL] [Abstract][Full Text] [Related]
53. Increased remission of early stage membranous nephropathy on long-term treatment with corticosteroid.
Funabiki K; Tomino Y; Shirato I; Yoshida M; Koide H
Nihon Jinzo Gakkai Shi; 1992 Sep; 34(9):997-1001. PubMed ID: 1479738
[TBL] [Abstract][Full Text] [Related]
54. [20 years' experience with the treatment of idiopathic membranous glomerulopathy. Retrospective study].
Knotoková V; Nĕmecek K
Cas Lek Cesk; 1990 Mar; 129(10):292-7. PubMed ID: 2340548
[TBL] [Abstract][Full Text] [Related]
55. [Clinical and histological observation of HBV glomerulonephritis treated with interferon-beta].
Ueda T; Gotoh Y; Shiroshita K; Sakurai T; Kataoka Y
Nihon Jinzo Gakkai Shi; 1990 Nov; 32(11):1153-9. PubMed ID: 2082050
[TBL] [Abstract][Full Text] [Related]
56. Membranous glomerulonephritis induced by 2-mercaptopropionylglycine (2-MPG).
Lindell A; Denneberg T; Eneström S; Fich C; Skogh T
Clin Nephrol; 1990 Sep; 34(3):108-15. PubMed ID: 2225561
[TBL] [Abstract][Full Text] [Related]
57. Relationship between interstitial infiltrates and steroid responsiveness of proteinuria in membranous nephropathy.
Alexopoulos E; Leontsini M; Papadimitriou M
Nephrol Dial Transplant; 1994; 9(6):623-9. PubMed ID: 7970087
[TBL] [Abstract][Full Text] [Related]
58. Long-term outcomes of initial therapy for idiopathic membranous nephropathy.
Sato M; Takei T; Moriyama T; Itabashi M; Nitta K
Clin Exp Nephrol; 2017 Oct; 21(5):842-851. PubMed ID: 27999961
[TBL] [Abstract][Full Text] [Related]
59. A retrospective study on the efficacy of corticosteroid-alone therapy in membranous nephropathy patients.
Kimura M; Toyoda M; Kobayashi K; Abe M; Kobayashi T; Kato M; Miyauchi M; Yamamoto N; Maruyama M; Umezono T; Nishina M; Yagame M; Endo M; Suzuki D
Intern Med; 2007; 46(19):1641-5. PubMed ID: 17917326
[TBL] [Abstract][Full Text] [Related]
60. [Recurrence of idiopathic membranous glomerulopathy].
Knotková V; Nĕmecek K; Ivasková E; Kupková L
Cas Lek Cesk; 1990 Oct; 129(40):1261-5. PubMed ID: 2257570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
